Study to Identify Biomarkers for Protein Intake

Overview

Results from observational studies suggest a small beneficial association between protein and blood pressure that may be mainly attributable to the intake of protein from plant sources. In epidemiological studies biomarkers of dietary intake are useful to estimate intake more reliably. Dietary studies using biomarkers of protein intake generally show stronger associations with health outcomes. However, data on biomarkers for specific types of protein (e.g. from dairy, meat, grain and legumes) are scarce. Therefore the purpose of this study is to identify new biomarkers for the intake of protein from meat, dairy and grain. In addition the secondary purpose is to investigate whether intake of protein from these sources influences kidney filtration rate and urinary acid excretion differentially.

Full Title of Study: “Study to Identify Biomarkers for Protein Intake; a Randomized, Fully Controlled Feeding Study”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Crossover Assignment
    • Masking: None (Open Label)
  • Study Primary Completion Date: April 2011

Interventions

  • Other: Run in diet
    • Fully controlled dietary period during 9 days. Participants will receive approximately 15 en% of protein. The amount of protein intake from dairy, meat, and grain will be equal to each other
  • Other: High meat protein diet
    • Fully controlled diet during 7 days. Participants will consume 18 en% protein, mainly from meat.
  • Other: High dairy protein diet
    • Fully controlled dietary intervention during 7 days. Participants will consume 20 en% protein. Mainly from dairy
  • Other: High grain protein diet
    • Fully controlled dietary intervention for 7 days. Participants will consume 20 en% of protein. Mainly from grain

Arms, Groups and Cohorts

  • Other: Run in
  • Experimental: High meat protein diet
  • Experimental: High dairy protein diet
  • Experimental: High grain protein diet

Clinical Trial Outcome Measures

Primary Measures

  • Differences between dietary periods in concentrations of potential biomerkers in blood and urine
    • Time Frame: On the last day of every one week intervention period
    • Potential biomarkers that will be measured are urinary creatinin, sulphate, carnosine, 1-MH, 3-MH, taurine,14N/15N and creatin in blood. Furthermore, amino acid profiling will be done in blood and urine to detect differences between dietary periods

Secondary Measures

  • Differences between dietary period in estimated renal filtration
    • Time Frame: blood and urine collection on the last day of each intervention period
    • Renal filtration will be estimated using bromide distribution in combination with bio-impedance measurement
  • Differences between dietary periods in urinary acid excretion
    • Time Frame: urine collection on the last day of each intervention period

Participating in This Clinical Trial

Inclusion Criteria

  • Age 18-40 years – BMI between 18.5 and 30 kg/m2 – Healthy (As judged by the participant) – Written informed consent obtained Exclusion Criteria:

  • Unable or unwilling to comply with study procedures. – Unusual dietary patterns, including high alcohol intakes (≥ 2 glasses/day) and a vegetarian diet – Recent (< 4 weeks) or current participation in a study with any investigational drug or dietary intervention – Usage of an energy restricted diet during the last two months – Weight loss or weight gain of 5 kg or more during the last two months – Smoking – Stomach or bowel diseases – Kidney disorders – Diabetes, thyroid disease, other endocrine disorders – Prevalent cardiovascular disease – Extreme sports (>8h/ wk) – Usage of any prescribed medication except for oral contraceptives – Use of systemic antibiotics in the period of 3 month prior to the study – For women: pregnant or lactating – For women: not using oral contraceptives – For women: Unwilling to use oral contraceptives for consecutively for at least the total study duration – Liver function parameters (ALAT, ASAT, and γ-GT) and renal function parameters (Serum creatinin) outside the normal range

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: 40 Years

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Wageningen University
  • Collaborator
    • Top Institute Food and Nutrition
  • Provider of Information About this Clinical Study
    • J.M. Geleijnse PhD, Wageningen University

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.